In a recent Japanese Society for Psoriasis Research analysis of 28,628 cases, herbal medicines (14.5%) ranked highest among systemic therapies used. This was followed by etretinate (7.6%), NSAIDs ...

Seeking traditional remedies for hair and scalp-related issues is a practice often passed down through generationa. One such remedy is fenugreek seeds, also known as dana metni. Here’s how these seeds ...

Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...

Herbal teas like chamomile, peppermint, and ginger tea offer several health-promoting properties and could help improve heart health, digestion, sleep quality, and more. Unlike true teas, which ...

As Holi 2025 is celebrated on March 14 this year, taking care of your skin is important and one that requires expert tips ...

Laser therapy is an emerging treatment that uses high-energy light to heat the nail and kill the fungus, while leaving ...

Opens in a new tab or window Despite recent significant advances in systemic therapies for psoriasis, topical treatment retains a prominent role for many patients. The American Academy of ...

Holi is a joyous festival, but synthetic colours can pose serious health risks, especially for those with allergies and respiratory issues. Experts warn about harmful chemicals in these colours and ...

Natural remedies for yeast infections like yogurt, probiotics, tea tree oil, and baking soda are commonly used to help fight yeast overgrowth and relieve symptoms like itching and discharge. Many ...

Chia seeds have emerged as a superfood with numerous skin detoxifying benefits. Packed with antioxidants, omega-3 fatty acids, and hydration propertie ...

In today's world, where appearances and well-being are increasingly valued, the quest for healthy, radiant skin has become a ...

Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra ...